Design Therapeutics Inc (DSGN)
5.56
+0.24
(+4.51%)
USD |
NASDAQ |
Nov 05, 16:00
5.56
0.00 (0.00%)
After-Hours: 18:59
Design Therapeutics Enterprise Value: 40.21M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 40.21M |
| November 01, 2024 | 33.41M |
| October 31, 2024 | 35.68M |
| October 30, 2024 | 54.36M |
| October 29, 2024 | 45.30M |
| October 28, 2024 | 52.10M |
| October 25, 2024 | 47.00M |
| October 24, 2024 | 41.90M |
| October 23, 2024 | 59.46M |
| October 22, 2024 | 60.02M |
| October 21, 2024 | 56.06M |
| October 18, 2024 | 55.78M |
| October 17, 2024 | 79.84M |
| October 16, 2024 | 58.89M |
| October 15, 2024 | 44.17M |
| October 14, 2024 | 30.58M |
| October 11, 2024 | 22.09M |
| October 10, 2024 | 3.402M |
| October 09, 2024 | 3.968M |
| October 08, 2024 | 17.56M |
| October 07, 2024 | -3.110M |
| October 04, 2024 | 22.09M |
| October 03, 2024 | 6.233M |
| October 02, 2024 | 20.39M |
| October 01, 2024 | 30.58M |
| Date | Value |
|---|---|
| September 30, 2024 | 43.60M |
| September 27, 2024 | 40.77M |
| September 26, 2024 | 45.87M |
| September 25, 2024 | 43.60M |
| September 24, 2024 | 45.30M |
| September 23, 2024 | 41.90M |
| September 20, 2024 | 71.91M |
| September 19, 2024 | 70.78M |
| September 18, 2024 | 58.32M |
| September 17, 2024 | 65.68M |
| September 16, 2024 | 53.23M |
| September 13, 2024 | 52.66M |
| September 12, 2024 | 69.65M |
| September 11, 2024 | 34.54M |
| September 10, 2024 | 58.32M |
| September 09, 2024 | 15.01M |
| September 06, 2024 | 3.402M |
| September 05, 2024 | 5.667M |
| September 04, 2024 | 11.33M |
| September 03, 2024 | 6.799M |
| August 30, 2024 | 7.931M |
| August 29, 2024 | 5.667M |
| August 28, 2024 | 5.667M |
| August 27, 2024 | 17.56M |
| August 26, 2024 | 42.47M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-188.32M
Minimum
Aug 21 2023
2.197B
Maximum
Mar 26 2021
273.69M
Average
144.17M
Median
Jan 26 2023
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.645M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 9.837M |
| Theriva Biologics Inc | -12.61M |
| Oragenics Inc | 1.996M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.79M |
| Total Expenses (Quarterly) | 15.04M |
| EPS Diluted (Quarterly) | -0.21 |
| Earnings Yield | -16.19% |